Résumé
Les prothèses servant à traiter les pathologies de la conduction cardiaque (stimulateurs cardiaques ou pacemakers), ou encore à prévenir la mort subite rythmique dans les populations à risque (défibrillateurs implantables) représentent une problématique quotidienne et croissante pour l’imagerie magnétique. Chaque année sont implantés en France environ 50 000 stimulateurs et 10 000 défibrillateurs. Le vieillissement de la population et l’élargissement des indications ont nettement fait progresser ces chiffres ces dix dernières années.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
Kalin R, Stanton MS (2005) Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing and clinical electrophysiology 28(4): 326–8
Vardas PE, Auricchio A, Blanc J-J, et al. (2007) The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 9(10): 959–98
Sasaki T, Hansford R, Zviman MM, et al. (2011) Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circulation 4(6): 662–70
Roguin A, Zviman MM, Meininger, et al. (2004) Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 110(5): 475–82
Irnich W, Irnich B, Bartsch C, et al. (2005) Do we need pacemakers resistant to magnetic resonance imaging? Europace 7(4): 353–65
Martin ET, Coman J, Shellock FG, et al. (2004) Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. Journal of the American College of Cardiology 43(7): 1315–24
Sommer T, Naehle CP, Yang A, et al. (2006) Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 114(12): 1285–92
Naehle CP, Strach K, Thomas D, et al. (2009) Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. Journal of the American College of Cardiology 54(6): 549–55
Levine GN, Gomes AS, Arai AE, et al. (2007) Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization. Circulation 116(24): 2878–91
Forleo GB, Santini L, Delia Rocca DG, et al. (2010) Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dual-chamber implant outcomes. Heart rhythm 7(6): 750–4
Nazarian S, Hansford R, Roguin A, et al. (2011) A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 155: 415–24
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Paris
About this paper
Cite this paper
Horvilleur, J., Lacotte, J. (2013). Nouveautés en matériel magnétocompatible. Le point de vue du rythmologue. In: Boyer, L., Guéret, P. (eds) Imagerie en coupes du cœur et des vaisseaux. Springer, Paris. https://doi.org/10.1007/978-2-8178-0435-4_4
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0435-4_4
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0434-7
Online ISBN: 978-2-8178-0435-4
eBook Packages: MedicineMedicine (R0)